ClinicalTrials.Veeva

Menu

Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

COVID-19 by SARS-CoV-2 Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04361565
20odontocovid01

Details and patient eligibility

About

A novel coronavirus SARS-CoV-2 HAS arose in 2019 in Wuhan, China. Beside the classical semiology of this infection, numerous patients described olfactory and teste disorders. These symptoms are not described in this coronavirus, neurotropism of coronaviridae has been documented before. The aim of the study is to evaluate prevalence of anosmia and dysgeusia (olfactory and taste disorders) in coronavirus diagnosed patients and compare with different clinical conditions. The second endpoint is to evaluate the duration of these symptoms in order to better understand the semiology of this infection.

Enrollment

81 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • COVID-19 diagnosed

Trial design

81 participants in 1 patient group

Individuals diagnosed for COVID-19

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems